Peptide of the Week: GLOW and KLOW — 10% Off This Week
Peptide of the Week: GLOW and KLOW — 10% Off This Week
TB-500 is one of the most significant synthetic research peptides in regenerative and cellular biology studies. It is the -terminally acetylated synthetic fragment () that mimics the central, highly active domain () of the naturally occurring 43-amino-acid protein, Thymosin Beta-4 () [1, 2].
The core research utility of TB-500 lies in its fundamental role as an actin regulator, making it invaluable for labs studying cellular structure, motility, and tissue repair mechanisms.
This guide details TB-500’s unique molecular function, its key applications in research, and the strict compliance standards required for its procurement in Canada.
What is it? Think of it as the “Mobilization Specialist” for your body’s repair crew. While other peptides help fix things locally, TB-500 signals repair cells to move to the site of an injury. Why is it being studied? Researchers use it to explore how to speed up the healing of “slow-to-heal” areas like tendons and ligaments. It is also investigated for its ability to reduce inflammation and increase flexibility in stiff or damaged joints. Top 3 Potential Benefits in Research:
Angiogenesis: Investigated for its ability to grow new blood vessels, bringing fresh oxygen and nutrients to damaged areas.
Cell Migration: Studied for its role in “recruiting” keratinocytes and fibroblasts to close wounds and rebuild muscle fibers.
Structural Flexibility: Observed to reduce adhesions and pathological scar tissue, potentially restoring a full range of motion.
TB-500’s mechanism is distinct from other regulatory peptides, focusing on the cytoskeleton—the internal scaffolding of the cell.
The primary function of and its analog, TB-500, is to bind to monomeric G-actin (globular actin) [1, 2].
Action: This actin-sequestering property prevents G-actin monomers from polymerizing into F-actin (filamentous actin), essentially maintaining a pool of free G-actin within the cell [2].
Research Relevance: The controlled release of G-actin from TB-500/ triggers rapid actin polymerization, which is the mechanical force driving cellular motility and structural changes [2.5, 3.4].
By regulating the actin cytoskeleton, TB-500 acts as a potent inducer of cellular migration, a critical step in tissue repair [1, 2].
Wound Healing Models: It facilitates the movement of key repair cells (like keratinocytes and fibroblasts) to injury sites [1.4].
Angiogenesis: TB-500 is intensely researched for its ability to promote angiogenesis (the formation of new blood vessels) by stimulating the migration and differentiation of endothelial cells [1.5, 3.2]. This process is crucial for supplying oxygen and nutrients to damaged or regenerating tissue.
Given that injectable peptides are frequently flagged by Health Canada as unauthorized prescription drugs when intended for human use, strict Research-Use-Only (RUO) compliance is mandatory [4.3, 4.4].
Analytical Standard: Luxara Labs supplies TB-500 with analytical purity, verified by HPLC and Mass Spectrometry (MS).
Documentation: A lot-specific Certificate of Analysis (COA) must accompany every batch, providing full transparency on identity () and concentration.
Legal Use: TB-500 is legal to procure and use only for controlled, in-vitro, scientific, and laboratory experiments.
Prohibition: It is NOT a therapeutic agent, drug, or supplement and is prohibited for human or animal use in Canada.
A batch-specific COA for TB-500 should list:
Researchers depend on this documentation for experimental reproducibility.
Most peptide suppliers in Canada ship via:
Typical Canadian delivery time:
📦 1–2 business days
Domestic shipping advantages:
Permitted research applications include:
✔ in-vitro biochemical testing
✔ cell-based models
✔ molecular pathway studies
✔ cytoskeleton investigations
✔ receptor binding assays
✔ stability profiling
Not permitted:
❌ human use
❌ animal use
❌ therapeutic claims
❌ dosing instructions
All research involving TB-500 in Canada must follow research-only guidelines.
Canadian researchers avoid suppliers that:
A reliable supplier prioritizes transparency and clarity.
Researchers repeatedly cite:
Domestic sourcing also removes the uncertainty of international customs delays.
Yes — for research, laboratory, and in-vitro use only.
No. It requires a legitimate research purpose, not a medical prescription.
No. TB-500 is not approved for therapeutic use.
Canadian labs typically use ≥99% purity.
Most orders arrive in 1–2 business days within Canada.
All information is for scientific and laboratory reference.
TB-500 referenced here is strictly for research, laboratory, and in-vitro use only — not for human or animal use.
Peptides in the United States
https://luxaralabs.com/peptides-usa/
An overview for US-based researchers explaining how research peptides are sourced from Canada, including documentation standards, quality verification, and cross-border considerations.
US Peptide Research Regulations
https://luxaralabs.com/peptide-research-regulations-usa/
A clear explanation of how research peptides are treated under US regulatory frameworks, including FDA oversight, import screening, labeling requirements, and compliance considerations.
Shipping Peptides to the USA
https://luxaralabs.com/shipping-peptides-to-usa/
A transparent guide outlining what US researchers can expect when shipping peptides from Canada, including customs review, delivery timelines, and potential shipment outcomes.
TB-500 is a synthetic version of the active 17–23 fragment of Thymosin Beta-4. Its primary mechanism involves high-affinity binding to G-actin (globular actin). By sequestering G-actin, TB-500 prevents its premature polymerization, allowing cells to maintain the flexibility needed for migration to the site of an injury. This allows TB-500 to act systemically; even when administered far from a wound, the peptide facilitates the transport of repair cells through the bloodstream to initiate healing where it is needed most.
Yes. TB-500 is a potent stimulator of angiogenesis, the formation of new capillary networks. It triggers endothelial cell migration and tube formation, which are essential for delivering nutrients and oxygen to oxygen-starved (ischemic) tissues. This makes it a critical subject for research into slow-healing connective tissues—like tendons and ligaments—which naturally have limited blood supply and often stall during the recovery phase.
While both are “healing peptides,” they are mechanistically complementary. BPC-157 is typically viewed as a “local” repair agent that targets tendon-to-bone healing and gut health. TB-500 provides the “systemic” support, enhancing cell motility and reducing overall inflammation. When used in the popular “Wolverine Stack,” the combination addresses both the structural integrity of the injury site (BPC-157) and the broader metabolic recovery of the surrounding muscle and vascular system (TB-500).
TB-500 is a small, 7-amino acid peptide that is relatively stable but sensitive to UV light and moisture. For long-term preservation, the lyophilized powder should be stored desiccated at -20°C. Once reconstituted with bacteriostatic water, the solution is stable for approximately 14–21 days when kept refrigerated at 2-8°C. Researchers should avoid vigorous shaking when reconstituting, as high shear force can denature the peptide chain; a gentle swirl is recommended to ensure clear dissolution.
Precision in regenerative medicine requires an absolute absence of truncated sequences or bacterial endotoxins that could trigger an unwanted immune response. Luxara Labs ensures every batch of TB-500 undergoes 3rd-party HPLC and MS testing to verify 99% purity. We provide expedited, temperature-stable shipping across Canada and the USA, ensuring that whether you are in Ontario, BC, or the Southern US, your research materials arrive with their molecular identity and actin-binding potency fully intact.
Join our list and get an instant 10% discount code — valid for first-time buyers.
